Michael Mortensen
Net worth: 546 076 $ as of 30/06/2026
Net worth: 546 076 $ as of 30/06/2026
Michael Wrang Mortensen is currently the EVP-Research, Development & Operations at BONESUPPORT HOLDING AB. Previously, he worked as the Director-Development & Supply at Nanovi Radiotherapy A. He holds a graduate degree from the Technical University of Denmark, a doctorate degree from the University of Copenhagen, and an MBA from AVT Business School A.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/12/2024 | 25,000 ( 0.04% ) | 546 076 $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| BONESUPPORT HOLDING AB | Chief Operating Officer | 01/12/2021 |
| Companies | Position | End |
|---|---|---|
Nanovi Radiotherapy A/S
Nanovi Radiotherapy A/S Medical SpecialtiesHealth Technology Operates as a medical device company that manufactures liquid fiducial markers to radiographically for cancer therapy | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Technical University of Denmark
Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BONESUPPORT HOLDING AB
BONESUPPORT HOLDING AB Medical SpecialtiesHealth Technology Develops and sells injectable, synthetic ceramic bone substitutes and injection accessories | Health Technology |
AVT Business School A/S
AVT Business School A/S Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanovi Radiotherapy A/S
Nanovi Radiotherapy A/S Medical SpecialtiesHealth Technology Operates as a medical device company that manufactures liquid fiducial markers to radiographically for cancer therapy | Health Technology |
Select your edition
All financial news and data tailored to specific country editions